Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-03
1999-08-17
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 2, 530317, 530318, A61K 3812, C07K 754
Patent
active
059393840
ABSTRACT:
Certain propanolamine compounds which have a cyclohexapeptidyl nucleus and which are found to have extremely active antibiotic activity with physical properties suitable for direct use in therapeutic compositions are described. A novel process for their preparation is also described.
REFERENCES:
patent: 4173629 (1979-11-01), Dreyfuss et al.
patent: 4287120 (1981-09-01), Abbott et al.
patent: 4293485 (1981-10-01), Debono
patent: 4293489 (1981-10-01), Debono
patent: 4320054 (1982-03-01), Abbott et al.
patent: 4931352 (1990-06-01), Fromtling et al.
patent: 4968608 (1990-11-01), Giacobbe et al.
patent: 5021341 (1991-06-01), Giacobbe et al.
patent: 5021403 (1991-06-01), Sesin et al.
patent: 5166135 (1992-11-01), Schmatz
Abstracts of the Belgiam Pats. 851,310 and 859,067.
The Merck Manual of Diagnosis and Therapy, p. 881, (1966).
Hammond Milton L.
Zambias Robert A.
Achutamurthy Ponnathapura
Daniel Mark R.
Korsen Elliott
Merck & Co. , Inc.
Wessendorf T. D.
LandOfFree
Cyclohexapeptidyl propanolamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclohexapeptidyl propanolamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexapeptidyl propanolamine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314810